1. Home
  2. INLF vs ENSC Comparison

INLF vs ENSC Comparison

Compare INLF & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

N/A

Current Price

$4.94

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.47

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLF
ENSC
Founded
2016
2003
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
3.9M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
INLF
ENSC
Price
$4.94
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1M
21.5M
Earning Date
03-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.24
EPS
N/A
N/A
Revenue
N/A
$5,066,650.00
Revenue This Year
N/A
$55.01
Revenue Next Year
N/A
$1,033.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.23
52 Week High
$9.91
$2.75

Technical Indicators

Market Signals
Indicator
INLF
ENSC
Relative Strength Index (RSI) 54.60 53.85
Support Level $3.09 $0.27
Resistance Level $9.19 $0.44
Average True Range (ATR) 1.22 0.09
MACD 0.00 0.00
Stochastic Oscillator 28.06 17.60

Price Performance

Historical Comparison
INLF
ENSC

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: